» Articles » PMID: 25935919

5-Fluorouracil Cardiotoxicity: Reversible Left Ventricular Systolic Dysfunction with Early Detection

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2015 May 4
PMID 25935919
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

A 33-year-old man presented to hospital with acute shortness of breath and evolving ST segment changes on ECG 3 days following a cycle of 5-fluorouracil (5-FU) for colon cancer. Despite no cardiac history, subsequent echocardiogram showed severe left ventricular systolic dysfunction. The patient was initially treated with heart failure medications and his coronary angiogram was normal. Chemotherapy was stopped and he was started on nitrates and calcium channel blockers. A repeat echocardiogram and cardiac MRI a week later showed complete resolution of his left ventricular dysfunction and he was discharged home. This case report summarises 5-FU cardiotoxicity, and emphasises the importance of early recognition and correct treatment, as left ventricular systolic dysfunction in this context is potentially reversible.

Citing Articles

Cardiotoxicity of anti-cancer drugs: cellular mechanisms and clinical implications.

Kwok C, Nolan M Front Cardiovasc Med. 2023; 10:1150569.

PMID: 37745115 PMC: 10516301. DOI: 10.3389/fcvm.2023.1150569.


PET Tracers for Imaging Cardiac Function in Cardio-oncology.

Kelly J, Babich J Curr Cardiol Rep. 2022; 24(3):247-260.

PMID: 35028820 PMC: 8934332. DOI: 10.1007/s11886-022-01641-4.


Dynamic observation of 5-fluorouracil-induced myocardial injury and mitochondrial autophagy in aging rats.

Li Y, Zhang Y, Zhou X, Lei X, Li X, Wei L Exp Ther Med. 2021; 22(6):1451.

PMID: 34721693 PMC: 8549097. DOI: 10.3892/etm.2021.10886.


What the Cardiologist Needs to Consider in the Management of Oncologic Patients with STEMI-Like Syndrome: A Case Report and Literature Review.

Aleksova A, Gagno G, Pierri A, Todaro C, Fluca A, Orlando V Pharmaceuticals (Basel). 2021; 14(6).

PMID: 34204714 PMC: 8231635. DOI: 10.3390/ph14060563.


Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications.

Bikiewicz A, Banach M, von Haehling S, Maciejewski M, Bielecka-Dabrowa A ESC Heart Fail. 2021; 8(4):2397-2418.

PMID: 33955207 PMC: 8318493. DOI: 10.1002/ehf2.13365.


References
1.
Sorrentino M, Kim J, Foderaro A, Truesdell A . 5-fluorouracil induced cardiotoxicity: review of the literature. Cardiol J. 2012; 19(5):453-8. DOI: 10.5603/cj.2012.0084. View

2.
Cwikiel M, Eskilsson J, Wieslander J, Stjernquist U, Albertsson M . The appearance of endothelium in small arteries after treatment with 5-fluorouracil. An electron microscopic study of late effects in rabbits. Scanning Microsc. 1996; 10(3):805-18; discussion 819. View

3.
Polk A, Vaage-Nilsen M, Vistisen K, Nielsen D . Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev. 2013; 39(8):974-84. DOI: 10.1016/j.ctrv.2013.03.005. View

4.
Bhushan S, Mcleod H, Walko C . Role of pharmacogenetics as predictive biomarkers of response and/or toxicity in the treatment of colorectal cancer. Clin Colorectal Cancer. 2009; 8(1):15-21. DOI: 10.3816/CCC.2009.n.003. View

5.
Khawaja M, Cafferkey C, Rajani R, Redwood S, Cunningham D . Cardiac complications and manifestations of chemotherapy for cancer. Heart. 2013; 100(14):1133-40. DOI: 10.1136/heartjnl-2013-303713. View